Just got a reply back from the SEC, obviously they wouldn't tell what they are doing , but they have expressed an interest in looking into irregular trades on 2 Dec. They did not say what action they are taking but are obviously looking into trading here.
I just fired off a written complaint to SEC via online complaints. Hope they look into this manipulation.
This one deserves reporting to SEC, down 1 cents all day on 850K , all of a sudden dropped 5 cents on 100K . Something isnt right here. Call SEC on this trading and report these Crooks.
Answer= NO, they don't, usually there IS one Idiot who fools himself with numerous IDS who is awake 24/7 right here using his thumbs. Nuff said until we see them burn in hell.
Just and honest opinion and it shall happen. No need even answering to these haters of this Company. Do the world global axis rotate? We will find out in a short covering which will deciminate these haters. Its all good and we will prosper despite the dark clouds on this messageboard.
What else ? Biotechs are taking a big hit and will run when its ready. Just after these manipulators finishes their raping of all Biotechs. The good one will run up.
It sure looks like someone is using scare tactics here for a purpose, bye the way, can anyone tell me when Data will be released in Dec? Also what trials do the Company have with a FDA Special Protocol access? Thanks.
How many other ID'S do you have? You said the same thing under another Aliases. I just happened to pick it up by doing some research on CYTR. Since you know so much about charts and pps, tell me when is Data release will be? Also tell me what the SPA with FDA is all about?
Diluting could see another 40 Million shares on OS. From experience, ARRY management is awaiting any move up pre-ASCO to announce raising cash. They believes that ASCO would propell it higher, it is a mistake to think so now that everyone knows they need cash. Arry needs lots of Dollars to continue its Trials, especially that they ar enow starting up with a new Trial. A long process.
Obviously you are not aware that large Pharma's do not partner in Phase I and II's. You are really mistaken that ARRY have partners who will put cash up without any returns especially that many Companies do not make it to Phase III with approvals. There is no Company out there who will fork out Hundreds of millions just for ARRY.
Expect another round of financing coming. They cannot sustain trials with limited cash on hand, I expect to see a diluting coming anytime. It was why she went down so hard today, everyone knows their cash at hand situation cannot take them to the finish line. Plain and simple , expect to hear about it soon before markets starts flattening
Certainty of India's approval since trials have completed almost 100%. This makes for a partnership by Shreya to actually provide the cash for manufacturing and distribution of sales all over Asia and the Middle East. Shreya knows that thieir market and are capable of producing Oral Recosulin at discounted cost. This is wim situation for Generex and Shreya. Generex can now rise from the ashes to a completely Independent money making machine. No money nor diluting needed if Shreya fund all Recusilin manufacturing in India's Generic market.
Sentiment: Strong Buy
My last conversation with Company they are compiling data from Phase II and preparing to present latest Phase II data to FDA meeting . As I heard that FDA meeting have been moved up pre Phase III trial commencement. This is good for all shareholders. I expect that GNBT will continue to rise with Management getting more visibility from Bloomberg Interview and potential partnership. As of current, latest Phase II data has not been released, it may come out better as announced.
It will be phase III in early 2012. Almost complete with Phase II, expanded trial groups will be announced with someone else with big bucks. Whenever a partnership is announced, stocks like these goes up tremendously, maybe for GNBT a few thousand percentage.
For a Cancer Treatment, this company is too cheap. After all Cancer Treatment are very expensive, and from viewing this VIDEO on Bloomberg states that the cost will be 1/4 compared to other Cancer treatment, plus life extension past 22 months. This is a given that this product will be successfuly passed by FDA with only PhaseII trials.
Unheard off, taking a look at this Video validates that GNBT Prostate and Breast Cancers are great Cancer news to victims. Bloomberg VIDEO showed the world about this upcoming vaccine, this alone would bring in Pharma's to investigate more about Antigen AE37 and their Vaccine.
Be ready anyday to hear that this Company may have a partner who will take this Vaccine to greater levels. As per Col Peoples, they want to make this Vaccine Pre-Cancer, a prevention of course.
Now that the World got to see GNBT/ Antigen products, you bet, that Companies who are developing Vaccines will start hunting for Antigen / GNBT .
Great sho, it explains a lot about their Cancer Vaccines, everyone should view this VIDEO.
No one can dispute these results, not even teh bashers who have numerous ID'S and are porting with CAPS on.
Read these results, and tonight the whole world will get to know that GNBT is on the road for higher PPS.
Take it from here, Antigen is about to wrap up Phase II, heading into Phase III with a partner. Could be the best Cancer drug to date for Breast Cancer victims. Don't let the bashers get to you, face these facts,